Here are four notes:
1. Weigao Orthopedic holds exclusive rights to sell, market and distribute Misonix’s BoneScalpel in the People’s Republic of China, Hong Kong and Macau.
2. The agreement will span five years.
3. Shandong Weigao Orthopedic Device Company Limited is a subsidiary of Shandong Weigao Group Medical Polymer Company Limited.
4. Weigao Orthopedic develops, produces and sells spine, trauma and joint orthopedic implants.
More articles on devices:
OrthAlign commercially launches UniAlign: 3 highlights
Amend Surgical earns FDA clearance for NanoFUSE BA: 4 things to know
$33.2B medical device outsourcing market to grow at a CAGR of 11.5% — 5 details
